Galectin Therapeutics' PIPE - III Round

Galectin Therapeutics raised a round of funding on February 06, 2006.

Galectin Therapeutics (OTC: PRWP), formerly Pro-Pharmaceuticals, is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the company's unique understanding …

Articles about Galectin Therapeutics' PIPE - III Round: